《Antibiotics-basel》雜志的最新年發文量為1731篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥學領域的學術影響力。
該刊聚焦于醫學-藥學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 11 Weeks 。
Antibiotics-basel 雜志發文統計
文章名稱引用次數
- Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity68
- Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007-2017)42
- The Continuing Threat of Methicillin-Resistant Staphylococcus aureus33
- Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria26
- Biocidal Agents Used for Disinfection Can Enhance Antibiotic Resistance in Gram-Negative Species24
- Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care24
- Antibiotic Discovery: Where Have We Come from, Where Do We Go?23
- Bacteriophages: Protagonists of a Post-Antibiotic Era21
- Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials19
- Synergistic Action of Phage and Antibiotics: Parameters to Enhance the Killing Efficacy Against Mono and Dual-Species Biofilms18
國家/地區發文量
- USA226
- Italy173
- Spain111
- England109
- GERMANY (FED REP GER)81
- Australia72
- Portugal66
- CHINA MAINLAND56
- France55
- South Korea45
